SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950116-03-002423
Filing Date
2003-04-30
Accepted
2003-04-30 16:10:15
Documents
3
Period of Report
2003-04-29

Document Format Files

Seq Description Document Type Size
1 4 form4.htm 4 22678
3 GRAPHIC emptybox.gif GRAPHIC 1218
4 GRAPHIC tickedbox.gif GRAPHIC 1267
  Complete submission text file 0000950116-03-002423.txt   27375
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Subject) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-25169 | Film No.: 03673079
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GENEREX BIOTECHNOLOGY CORP 33 HARBOR SQUARE STE 202 TORONTO ONTARIO CANADA M5J2G2
Business Address 33 HARBOUR SQUARE STE 202 TORONTO ONTARIO CANADA M5H2G2 A1 00000 4163642551
PERRI ROSE C (Reporting) CIK: 0001125858 (see all company filings)